Myriad Inks Deal with Pharma Mar to Provide BRCA Testing for Drug Candidate
July 26, 2012
Myriad Inks Deal with Pharma Mar to Provide BRCA Testing for Drug Candidate
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- After Appeals Court Victory, Myriad Looks to Debunk 'Misconceptions' on How it Enforces DNA Patents
August 22, 2012 / Pharmacogenomics Reporter - Myriad Genetics, Pharma Mar Explore PGx Strategy for DNA-Damaging Synthetic Alkaloid PM1183
August 1, 2012 / Pharmacogenomics Reporter - Myriad Prepared to Make Small IP Sacrifice to Aussies in Light of Landmark US Patent Case
October 6, 2010 / Pharmacogenomics Reporter - Prostate Cancer MDx Competition Heating Up; New Data from Genomic Health, Myriad
May 15, 2013 / Pharmacogenomics Reporter - Myriad to Launch NGS MyRisk Hereditary Cancer Panel this Year, Replace Existing Tests by Mid-2015
May 15, 2013 / Clinical Sequencing News